Your browser doesn't support javascript.
loading
RAS interaction with Sin1 is dispensable for mTORC2 assembly and activity.
Castel, Pau; Dharmaiah, Srisathiyanarayanan; Sale, Matthew J; Messing, Simon; Rizzuto, Gabrielle; Cuevas-Navarro, Antonio; Cheng, Alice; Trnka, Michael J; Urisman, Anatoly; Esposito, Dominic; Simanshu, Dhirendra K; McCormick, Frank.
Afiliação
  • Castel P; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158.
  • Dharmaiah S; National Cancer Institute (NCI) RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702.
  • Sale MJ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158.
  • Messing S; National Cancer Institute (NCI) RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702.
  • Rizzuto G; Department of Anatomic Pathology, University of California, San Francisco, CA 94158.
  • Cuevas-Navarro A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158.
  • Cheng A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158.
  • Trnka MJ; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
  • Urisman A; Department of Anatomic Pathology, University of California, San Francisco, CA 94158.
  • Esposito D; National Cancer Institute (NCI) RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702.
  • Simanshu DK; National Cancer Institute (NCI) RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702; Frank.mccormick@ucsf.edu dhirendra.simanshu@nih.gov.
  • McCormick F; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158; Frank.mccormick@ucsf.edu dhirendra.simanshu@nih.gov.
Proc Natl Acad Sci U S A ; 118(33)2021 08 17.
Article em En | MEDLINE | ID: mdl-34380736
ABSTRACT
RAS proteins are molecular switches that interact with effector proteins when bound to guanosine triphosphate, stimulating downstream signaling in response to multiple stimuli. Although several canonical downstream effectors have been extensively studied and tested as potential targets for RAS-driven cancers, many of these remain poorly characterized. In this study, we undertook a biochemical and structural approach to further study the role of Sin1 as a RAS effector. Sin1 interacted predominantly with KRAS isoform 4A in cells through an atypical RAS-binding domain that we have characterized by X-ray crystallography. Despite the essential role of Sin1 in the assembly and activity of mTORC2, we find that the interaction with RAS is not required for these functions. Cells and mice expressing a mutant of Sin1 that is unable to bind RAS are proficient for activation and assembly of mTORC2. Our results suggest that Sin1 is a bona fide RAS effector that regulates downstream signaling in an mTORC2-independent manner.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Proteínas Adaptadoras de Transdução de Sinal / Alvo Mecanístico do Complexo 2 de Rapamicina Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Proto-Oncogênicas p21(ras) / Proteínas Adaptadoras de Transdução de Sinal / Alvo Mecanístico do Complexo 2 de Rapamicina Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2021 Tipo de documento: Article